| Application no. and date | 11176719.0 (espacenet) (Federated) (European Patent Register), 20030320 | | Patent/reg. no. and date | DK/EP 2420490, 20160720 | | Publication date | 20120222 | | Priority no. and date | US 366515 P, 20020320, US 438450 P, 20030107 | | EP pub. no. and date |
EP 2420490 20120222 | | Effective date | | | Applicant/owner | Amgen (Europe) GmbH, Floor 6-8
Suurstoffi 22
Risch-Rotkreuz 6343, CH | | Applicant ref. no. | 59799DK01 | | Inventor | Ge, Chuansheng, 9 Breckenridge Court
Belle Mead, NJ New Jersey 08502, US,
Muller, George, W., P.O. Box 3688
Rancho Santa Fe, CA California 92067, US,
Man, Hon-Wah, 27 Grant Way
Princeton, NJ New Jersey 08540, US,
SCHAFER, Peter, H., 237 Monroe Avenue
Belle Mead, NJ 08502, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/4035 (2006.01) , A61P 29/00 (2006.01) , C07C 317/28 (2006.01) , C07D 209/48 (2006.01) | | Title | Fremgangsmåde til fremstilling af (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindolin-1,3-dion | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
